Skip to main content
Top
Published in: Diabetologia 5/2012

01-05-2012 | Short Communication

Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring

Authors: M. E. Miettinen, L. Reinert, L. Kinnunen, V. Harjutsalo, P. Koskela, H.-M. Surcel, C. Lamberg-Allardt, J. Tuomilehto

Published in: Diabetologia | Issue 5/2012

Login to get access

Abstract

Aims/hypothesis

Vitamin D deficiency during the fetal period or infancy is one of the suggested environmental factors for type 1 diabetes and for its increasing incidence. To test this hypothesis we compared serum 25-hydroxyvitamin D (25(OH)D) levels during early pregnancy in mothers of children who subsequently developed type 1 diabetes (case mothers) with mothers of non-diabetic healthy children (control mothers) of the same age.

Methods

Children with type 1 diabetes were identified from the nationwide prescription register. 25(OH)D concentration was measured from serum samples collected during the first trimester of pregnancy from all Finnish women (Finnish Maternity Cohort). A total of 343 case mothers and 343 control mothers were included in the study. Samples were collected throughout the year. Samples from case and control mothers were matched on the day of collection.

Results

Mean 25(OH)D levels in case mothers (43.9 nmol/l) and control mothers (43.7 nmol/l) were not different. Of all mothers, 481 (70.1%) were vitamin D-deficient or -insufficient.

Conclusions/interpretation

No difference was found in serum 25(OH)D concentrations during first trimester of pregnancy between mothers whose children later on developed type 1 diabetes, and mothers of non-diabetic ‘ healthy’ children of the same age. It is difficult to detect possible effects of mothers’ vitamin D deficiency during early pregnancy on the development of type 1 diabetes in the offspring in this population, as such a large proportion of mothers were vitamin D-deficient or -insufficient.
Literature
1.
go back to reference Hyppönen E (2010) Vitamin D and increasing incidence of type 1 diabetes—evidence for an association? Diabetes Obes Metab 12(9):737–743PubMedCrossRef Hyppönen E (2010) Vitamin D and increasing incidence of type 1 diabetes—evidence for an association? Diabetes Obes Metab 12(9):737–743PubMedCrossRef
2.
go back to reference Harjutsalo V, Sjöberg L, Tuomilehto J (2008) Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 371(9626):1777–1782PubMedCrossRef Harjutsalo V, Sjöberg L, Tuomilehto J (2008) Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 371(9626):1777–1782PubMedCrossRef
3.
go back to reference Kauppi M, Impivaara O, Mäki J et al (2009) Vitamin D status and common risk factors for bone fragility as determinants of quantitative ultrasound variables in a nationally representative population sample. Bone 45(1):119–124PubMedCrossRef Kauppi M, Impivaara O, Mäki J et al (2009) Vitamin D status and common risk factors for bone fragility as determinants of quantitative ultrasound variables in a nationally representative population sample. Bone 45(1):119–124PubMedCrossRef
4.
go back to reference EURODIAB Substudy 2 Study Group (1999) Vitamin D supplement in early childhood and risk for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 42:51–54CrossRef EURODIAB Substudy 2 Study Group (1999) Vitamin D supplement in early childhood and risk for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 42:51–54CrossRef
5.
go back to reference Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth–cohort study. Lancet 358(9292):1500–1503PubMedCrossRef Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth–cohort study. Lancet 358(9292):1500–1503PubMedCrossRef
6.
go back to reference Stene LC, Joner G, Norwegian Childhood Diabetes Study Group (2003) Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case–control study. Am J Clin Nutr 78(6):1128–1134PubMed Stene LC, Joner G, Norwegian Childhood Diabetes Study Group (2003) Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case–control study. Am J Clin Nutr 78(6):1128–1134PubMed
7.
go back to reference Brekke HK, Ludvigsson J (2007) Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatr Diabetes 8(1):11–14PubMedCrossRef Brekke HK, Ludvigsson J (2007) Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatr Diabetes 8(1):11–14PubMedCrossRef
8.
go back to reference Simpson M, Brady H, Yin X et al (2011) No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 54(11):2779–2788PubMedCrossRef Simpson M, Brady H, Yin X et al (2011) No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 54(11):2779–2788PubMedCrossRef
9.
go back to reference Stene LC, Ulriksen J, Magnus P, Joner G (2000) Use of cod-liver oil during pregnancy associated with lower risk of type 1 diabetes in the offspring. Diabetologia 43:1093–1098PubMedCrossRef Stene LC, Ulriksen J, Magnus P, Joner G (2000) Use of cod-liver oil during pregnancy associated with lower risk of type 1 diabetes in the offspring. Diabetologia 43:1093–1098PubMedCrossRef
10.
go back to reference Marjamäki L, Niinistö S, Kenward MG et al (2010) Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 53(8):1599–1607PubMedCrossRef Marjamäki L, Niinistö S, Kenward MG et al (2010) Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 53(8):1599–1607PubMedCrossRef
11.
go back to reference Nordic Council of Ministers (2004) Nordic nutrition recommendations 2004. Integrating nutrition and physical activity. Nordic Council of Ministers, Århus Nordic Council of Ministers (2004) Nordic nutrition recommendations 2004. Integrating nutrition and physical activity. Nordic Council of Ministers, Århus
12.
go back to reference Institute of Medicine, Food and Nutrition Board (2011) Dietary reference intakes for calcium and vitamin D. National Academy Press, Washington Institute of Medicine, Food and Nutrition Board (2011) Dietary reference intakes for calcium and vitamin D. National Academy Press, Washington
13.
go back to reference Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28PubMed Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28PubMed
14.
go back to reference Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al (1992) Epidemiology of childhood diabetes mellitus in Finland—background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. The Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia 35:70–76PubMedCrossRef Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al (1992) Epidemiology of childhood diabetes mellitus in Finland—background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. The Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia 35:70–76PubMedCrossRef
15.
go back to reference Viljakainen HT, Saarnio E, Hytinantti T et al (2010) Maternal vitamin D status determines bone variables in the newborn. J Clin Endocrinol Metab 95(4):1749–1757PubMedCrossRef Viljakainen HT, Saarnio E, Hytinantti T et al (2010) Maternal vitamin D status determines bone variables in the newborn. J Clin Endocrinol Metab 95(4):1749–1757PubMedCrossRef
Metadata
Title
Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring
Authors
M. E. Miettinen
L. Reinert
L. Kinnunen
V. Harjutsalo
P. Koskela
H.-M. Surcel
C. Lamberg-Allardt
J. Tuomilehto
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2458-8

Other articles of this Issue 5/2012

Diabetologia 5/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.